BioVaxys Technology Corp. announced that Charles J. Dunton, MD, has joined BioVaxys as an Advisor to help provide additional scientific support for BVX-0918A, the Company's ovarian cancer vaccine candidate, and its planned marketing and sale of Papilocare in the United States. Dr. Dunton, a top global opinion leader, is a gynecologist/oncologist in Indiana. He received his medical degree from Jefferson Medical College and has been in practice for more than 30 years. Dr. Dunton has been Chief, Division of Gynecologic Oncology Department of Obstetrics and Gynecology, Main Line Health and Professor, Department of Obstetrics and Gynecology, Jefferson Medical College, and has been named one of America's Top Doctors for Cancer by U.S. News & World Report. His clinical background and research interests match those of BioVaxys and include ovarian cancer, cervical cancer, and human papillomavirus ("HPV"). He is Past President and board member of the American Society for Colposcopy and Cervical Pathology and was on the Editorial Board of the Journal of Lower Genital Tract Disease.